Fifth Third Bancorp Novartis Ag Transaction History
Fifth Third Bancorp
- $26.1 Billion
- Q2 2024
A detailed history of Fifth Third Bancorp transactions in Novartis Ag stock. As of the latest transaction made, Fifth Third Bancorp holds 47,066 shares of NVS stock, worth $5.44 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
47,066
Previous 60,625
22.37%
Holding current value
$5.44 Million
Previous $5.86 Million
14.56%
% of portfolio
0.02%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.41 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$857 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$856 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$687 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...